ClinicalTrials.gg
RecruitingNCT04130789PSSS_digitalUpdated Mar 5, 2025

Personalized Swiss Sepsis Study

An observational study in Sepsis, sponsored by University Hospital, Basel, Switzerland. Recruiting at 16 sites in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-03-05.

Sponsored by University Hospital, Basel, Switzerland · Observational

How we know

From the registry’s dates

  • Started Nov 2019; still recruiting 7 years later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
17,500
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 11 studies in Sepsis by University Hospital, Basel, Switzerland — 2 open to participants now, 2 under way, none of them phase 3. Sepsis · University Hospital, Basel, Switzerland.

Started
2019
with 1 other
Observational
8 of 11
1 open now
Registered
5th of 11
by date

Among the 11 studies in Sepsis by University Hospital, Basel, Switzerland, this one is one of 2 that started in 2019, is one of 8 observational ones, and was the 5th registered.

Sepsis

2,425 studies on the registry are indexed under Sepsis; 543 are open to participants now.

Browse Sepsis studies →

Open to participants now

2 of the 11 studies in Sepsis by University Hospital, Basel, Switzerland are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 319 Sepsis studies recruiting now, 212 (66%) set no upper age limit and 52 (16%) stop at 75 or younger; 67 take children under 18; 43 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Sepsis by University Hospital, Basel, Switzerland, or all of them as a file.
02

Study summary

This multi-center study is to focus on patients with sepsis in Intensive Care Units (ICUs) in order to better understand the complex host-pathogen interaction and clinical heterogeneity associated with sepsis. Understanding this heterogeneity may allow the development of novel diagnostic approaches. Data from patients will be analyzed using state-of-the art analytical algorithms for biomarker discovery including machine learning and multidimensional mathematical modelling to explore the large datasets generated. In order to discover digital biomarkers for the study endpoints a case-control study design will be used to compare data patterns from patients with sepsis (cases) and those without sepsis (controls).

03

Conditions studied

  • Sepsis

Browse trials for

Keywords

  • clinical data warehouse (CDWH)
  • machine learning
  • data-driven algorithms
  • multi-dimensional modelling
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

ICU patients on a Swiss University Hospital ICU from 01.08.2019

Eligibility criteria

Inclusion Criteria:

  • Patients admitted to an ICU on a Swiss University Hospital.
  • Patients expected to stay at least 24h on the ICU

Inclusion Criteria (cases)

  • Present at admission to ICU or subsequent development of sepsis 3.0 criteria

Inclusion Criteria (controls)

  • Patients not fulfilling sepsis definition during the ICU stay

Exclusion Criteria:

  • Decline of general consent or any other negative statement against using data for research.
  • Patients with a clear elective stay on the ICUs.
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
17,500 participants (estimated)
Patient registry
No

Groups and cohorts

  • patients with sepsis (cases)

    patients who developed or were admitted with sepsis to the ICU (cases)

    Other: compare data patterns by data-driven algorithms to determine sepsis · Other: compare data patterns by data-driven algorithms to predict sepsis-related mortality

  • patients without sepsis (controls)

    patients who did not develop sepsis (controls).

    Other: compare data patterns by data-driven algorithms to determine sepsis · Other: compare data patterns by data-driven algorithms to predict sepsis-related mortality

Interventions

  • Othercompare data patterns by data-driven algorithms to determine sepsis

    compare data patterns by data-driven algorithms including machine learning and multi-dimensional modelling to reliably determine sepsis

  • Othercompare data patterns by data-driven algorithms to predict sepsis-related mortality

    compare data patterns by data-driven algorithms including machine learning and multi-dimensional modelling to to predict sepsis-related mortality

06

What researchers measure

Primary outcomes

  1. sepsis-related mortality (sensitivity)

    Algorithm to predict sepsis-related mortality (sensitivity)

    Time frame: time- series data collected from hospital entry until maximum 12 months after hospital exit (no exact time point specified)

  2. sepsis-related mortality (specificity)

    Algorithm to predict sepsis-related mortality (specificity)

    Time frame: time- series data collected from hospital entry until maximum 12 months after hospital exit (no exact time point specified)

  3. Determination of sepsis

    Algorithm to determine sepsis at an early stage (at least 12 hours before classical definitions)

    Time frame: time- series data collected from hospital entry until hospital exit; an average of 1 month (no exact time point specified)

07

Study locations

13 of 16 sites recruiting
  • Clinical Microbiology, University Hospital Basel
    Basel, 4031, Switzerland
    Recruiting
  • Infectious Diseases and Hospital Epidemiology, University Hospital Basel
    Basel, 4031, Switzerland
    Recruiting
    • Manuel Battegay, Prof Dr med · Contact
  • Medical Intensive Care Unit; University Hospital Basel
    Basel, 4031, Switzerland
    Recruiting
    • Stephan Marsch, Prof. Dr. MD · Contact
  • Surgical Intensive Care Unit, University Hospital Basel
    Basel, 4031, Switzerland
    Recruiting
    • Martin Siegemund, Prof. Dr. MD · Contact
  • Institute for Infectious Diseases, University of Bern
    Bern, 3001, Switzerland
    Recruiting
    • Stephen Leib, Prof. Dr. MD · Contact
  • Division Infectious Diseases, University Hospital Bern
    Bern, 3010, Switzerland
    Recruiting
    • Hansjakob Furrer, Prof.Dr.med · Contact
  • Intensive Care Medicine, University Hospital Bern
    Bern, 3010, Switzerland
    Recruiting
    • Stephan Jakob, Prof. Dr. MD · Contact
  • Division Bacteriology Laboratory, University Hospital Geneva
    Geneva, 1205, Switzerland
    Recruiting
    • Jacques Schrenzel, Prof Dr med · Contact
  • Division Infectious Diseases, University Hospital Geneva
    Geneva, 1205, Switzerland
    Recruiting
    • Laurent Kaiser, Prof. Dr. MD · Contact
  • Intensive Care Medicine, University Hospital Geneva
    Geneva, 1205, Switzerland
    Recruiting
    • Jérôme Pugin, Prof. Dr. MD · Contact
  • Division Intensive Care Medicine, University Hospital Lausanne
    Lausanne, 1011, Switzerland
    Recruiting
    • Philippe Eckert, Prof. Dr. MD · Contact
  • Institute of Microbiology, University Hospital Lausanne
    Lausanne, 1011, Switzerland
    Recruiting
    • Gilbert Greub, Prof. Dr. MD · Contact
  • Service Infectious Diseases, University Hospital Lausanne
    Lausanne, 1011, Switzerland
    Recruiting
    • Thierry Calandra, Prof. Dr. MD · Contact
  • Institute for Medical Microbiology, University Hospital Zurich
    Zürich, 8006, Switzerland
    Not yet recruiting
    • Reinhard Zbinden, Prof. Dr. MD · Contact
  • Division Infectious Diseases, University Hospital Zurich
    Zürich, 8091, Switzerland
    Not yet recruiting
    • Annelies Zinkernagel, Prof. Dr. MD · Contact
  • Institute for Intensive Medicine, University Hospital Zurich
    Zürich, 8091, Switzerland
    Not yet recruiting
    • Reto Schüpbach, Prof. Dr. MD · Contact
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2019 to primary completion in May 2022, 30 months.

Of 496 non-industry observational studies under Sepsis, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 57. This study's 30 months is close to that.

Counting every sponsor, half of 548 studies reached it within 27 months; a quarter within 12 and three quarters within 55.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 15, 2019
First posted
Oct 17, 2019
StartActual
Nov 15, 2019
Primary completionActual
May 31, 2022
CompletionEst.
Dec 2025
Last update
Mar 5, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 5, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04130789
Collaborators
Swiss Personalized Health Network (SPHN), Personalized Health and Related Technologies (PHRT) initiative of ETH Zürich
Responsible party
Sponsor
First posted
Oct 17, 2019
Start date
Nov 15, 2019
Primary completion
May 31, 2022
Completion
Dec 2025 (estimated)
Last update
Mar 5, 2025

Study contacts

Adrian Egli, PD Dr.
Contact
adrian.egli@usb.ch
+41 61 556 5749
Adrian Egli, PD Dr.
principal investigator · Clinical Microbiology, University Hospital Basel

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion